[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN109939135A - A kind of ketogenic parenteral nutrition solution and preparation method thereof - Google Patents

A kind of ketogenic parenteral nutrition solution and preparation method thereof Download PDF

Info

Publication number
CN109939135A
CN109939135A CN201910213658.3A CN201910213658A CN109939135A CN 109939135 A CN109939135 A CN 109939135A CN 201910213658 A CN201910213658 A CN 201910213658A CN 109939135 A CN109939135 A CN 109939135A
Authority
CN
China
Prior art keywords
vitamin
ketogenic
solution
glucose
parenteral nutrition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910213658.3A
Other languages
Chinese (zh)
Inventor
孔粼
吕麟亚
吴青
贾运涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital of Chongqing Medical University
Original Assignee
Childrens Hospital of Chongqing Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital of Chongqing Medical University filed Critical Childrens Hospital of Chongqing Medical University
Priority to CN201910213658.3A priority Critical patent/CN109939135A/en
Publication of CN109939135A publication Critical patent/CN109939135A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a kind of raw ketone parenteral nutrient solutions and preparation method thereof, including the following substance being dissolved in water for injection: amino acid, lipoid material, glucose, vitamin, minerals, emulsifier and sodium acetate;The mass fraction of each component are as follows: amino acid 1 .80~3.3g/100mL, 6.5~8.0g/100mL of lipoid material, 0.2~0.7g/100mL of glucose, vitamin 28.93mg/100mL, minerals 327.33mg/100ml, 1.32~1.49g/100mL of emulsifier, 2.34~4.29mmol/100mL of sodium acetate.Provided low sugar low amino acid nutrient solution prescription high in fat, for treating intractable epilepsy and other hereditary metabolic disorders such as glucose transporter deficiency disease, pyruvic dehydrogenase deficiency, Partial tumors etc. well, the blank of raw ketone parenteral nutrient solution technology has been filled up.

Description

一种生酮肠外营养液及其制备方法A kind of ketogenic parenteral nutrition solution and preparation method thereof

技术领域technical field

本发明涉及医用肠外营养制剂,具体涉及一种生酮肠外营养液及其制备方法。The invention relates to a medical parenteral nutrition preparation, in particular to a ketogenic parenteral nutrition solution and a preparation method thereof.

背景技术Background technique

生酮饮食是一种高脂肪低碳水化合物的饮食,最初于1921年由Mayo Clinic的Wilder博士提出并应用于治疗难治性癫痫,取得较好的疗效(陈文杰,秦炯.生酮饮食疗法治疗儿童难治性癫痫作用机制研究进展[J].中华实用儿科临床杂志,2017,32(24):1912-1914.)。此后,在其他遗传代谢性疾病如葡萄糖载体缺乏症、丙酮酸脱氢酶缺乏症、部分肿瘤(Vidali S,Aminzadeh S,Lambert B,et al.Mitochondria:the ketogenic diet-ametabolism-based therapy.Int J Biochem Cell Biol.2015;63:55-59.)等中运用,均取得不错的效果。然而,不管是上述那种患者,一旦发生胃肠道梗阻、肠瘘、活动性出血等疾病则不得不禁食(焦广宇,李增宁,陈伟.临床营养学[M].北京:人民卫生出版社,2017:106.),生酮饮食无法延续。这种情况常常给临床医生造成治疗困难:如果通过普通的葡萄糖或氨基酸进补液,会导致患者酮体迅速降低,可能诱发原本控制好的癫痫等再次发作。如果单纯使用脂肪乳剂,又可能导致恶心、呕吐、胆汁淤积等肠外营养并发症。因此,研发科学的、安全有效的、配比合理的生酮肠外营养配方,对于生酮患者有特殊的意义。The ketogenic diet is a high-fat and low-carbohydrate diet, which was first proposed by Dr. Wilder of Mayo Clinic in 1921 and applied to the treatment of refractory epilepsy, and achieved good results (Chen Wenjie, Qin Jiong. Ketogenic diet therapy for children Research progress on the mechanism of refractory epilepsy[J]. Chinese Journal of Practical Pediatrics, 2017, 32(24): 1912-1914.). Since then, in other genetic metabolic diseases such as glucose carrier deficiency, pyruvate dehydrogenase deficiency, some tumors (Vidali S, Aminzadeh S, Lambert B, et al. Mitochondria: the ketogenic diet-ametabolism-based therapy. Int J Biochem Cell Biol. 2015; 63: 55-59.), etc., all achieved good results. However, no matter the above-mentioned patients, once they have gastrointestinal obstruction, intestinal fistula, active bleeding and other diseases, they have to fast (Jiao Guangyu, Li Zengning, Chen Wei. Clinical Nutrition [M]. Beijing: People's Health Publishing House) , 2017:106.), the ketogenic diet cannot continue. This situation often makes treatment difficult for clinicians: if normal glucose or amino acids are used for rehydration, the patient's ketone bodies will rapidly decrease, which may induce seizures such as epilepsy that were originally controlled. If the fat emulsion is used alone, it may lead to complications of parenteral nutrition such as nausea, vomiting, and cholestasis. Therefore, the development of scientific, safe and effective ketogenic parenteral nutrition formulas with reasonable proportions is of special significance for ketogenic patients.

中国专利数据库中涉及生酮配方的申请全部为经胃肠道补充的制剂。迄今为止,并无专用于肠道外营养(经过静脉输注)的生酮配方专利。All applications involving ketogenic formulations in the Chinese patent database are formulations supplemented by the gastrointestinal tract. To date, there are no patents on ketogenic formulations dedicated to parenteral nutrition (via intravenous infusion).

发明内容SUMMARY OF THE INVENTION

本发明所要解决的技术问题是提供一种生酮肠外营养液及其制备方法,所提供的高脂低糖低氨基酸营养液配方,在患者不得不禁食的情况下,通过输入该营养液很好的治疗难治性癫痫以及其他遗传代谢性疾病如葡萄糖载体缺乏症、丙酮酸脱氢酶缺乏症、部分肿瘤等,填补了生酮肠外营养液技术的空白。The technical problem to be solved by the present invention is to provide a ketogenic parenteral nutrient solution and a preparation method thereof. The high-fat, low-sugar, and low-amino acid nutrient solution formula provided by the present invention can be easily absorbed by the patient when the patient has to fast. Good treatment of refractory epilepsy and other genetic metabolic diseases such as glucose carrier deficiency, pyruvate dehydrogenase deficiency, some tumors, etc., fill the gap of ketogenic parenteral nutrition technology.

本发明解决上述技术问题的技术方案如下:一种生酮肠外营养液,包括溶解在注射用水中的以下物质:氨基酸、脂肪类物质、葡萄糖、维生素、矿物质、乳化剂和醋酸钠;各组分的质量分数为:氨基酸1.80~3.3g/100mL,脂肪类物质6.5~8.0g/100mL,葡萄糖0.2~0.7g/100mL,维生素28.93mg/100mL,矿物质327.33mg/100ml,乳化剂1.32~1.49g/100mL,醋酸钠2.34~4.29mmol/100mL。The technical solution of the present invention to solve the above-mentioned technical problems is as follows: a ketogenic parenteral nutrition solution, comprising the following substances dissolved in water for injection: amino acids, fatty substances, glucose, vitamins, minerals, emulsifiers and sodium acetate; The mass fraction of components is: amino acid 1.80~3.3g/100mL, fatty substance 6.5~8.0g/100mL, glucose 0.2~0.7g/100mL, vitamin 28.93mg/100mL, mineral 327.33mg/100ml, emulsifier 1.32~ 1.49g/100mL, sodium acetate 2.34~4.29mmol/100mL.

本发明的有益效果是:本发明主要用于已采用生酮饮食控制疾病的患者(如控制癫痫发作)在其发生较重的胃肠功能障碍(如肠梗阻、活动性出血等)而禁食时,不能使用普通高糖低脂等普通肠外营养配方状态,本发明可以有效维持禁食患儿的血酮水平,避免疾病发作,同时保证总能量摄入,是生酮患儿禁食期间的理想营养保障,同时,与普通肠外营养液高糖低脂适量氨基酸配方不同,本发明为高脂低糖低氨基酸配方,根据生酮患儿(难治性癫痫或其他相关代谢疾病)的对供能营养素的特殊需求,提高了肠外营养配方中脂肪乳剂的比例,降低了氨基酸和葡萄糖的比例,确定维生素和矿物质的需求,在患儿中使用安全有效,输注后可以维患者血酮在理想范围、血糖也在正常范围,不诱发患者癫痫发作(或诱发糖代谢异常患者的高乳酸血症),有效解决服用生酮饮食的患者在禁食期间的营养需求;该配方的脂肪类物质可以防止高血脂、肝损害、胆汁淤积,尽可能减少高脂配方的不良反应;配方中强化了维生素B2、烟酸、泛酸的剂量,可以加快有脂肪β氧化,进一步减脂肪超载的可能;该肠外营养配方渗透压均小于600mOsm/L,在外周静脉可以耐受的范围内(900mOsm/L),患者输注疼痛感小,且不容易引起脉管炎;所述葡萄糖为医用葡萄糖溶液中的葡萄糖,少量的葡萄糖溶液可以平衡脂肪代谢,不影响生酮,同时降低低血糖发生的几率;乳化剂使得脂肪类物质成为可吸收的形式;矿物质的作用是维持人体正常生理功能;氨基酸的作用保证儿童对必需氨基酸的需求,避免负氮平衡;醋酸钠是无水醋酸在最终溶液中的存在模式,无水醋酸是为了使生酮营养液的PH能够稳定在人体能够接受的范围内,保证输注安全性。The beneficial effects of the present invention are as follows: the present invention is mainly used for patients who have adopted ketogenic diet to control diseases (such as controlling epilepsy) and fasting when they have severe gastrointestinal dysfunction (such as intestinal obstruction, active bleeding, etc.). At the same time, the state of common parenteral nutrition formulas such as common high sugar and low fat cannot be used, and the present invention can effectively maintain the blood ketone level of fasting children, avoid disease outbreaks, and at the same time ensure total energy intake, which is the best time for ketogenic children during fasting. At the same time, the present invention is a high-fat, low-sugar and low-amino acid formula, which is different from ordinary parenteral nutrition solution high-sugar, low-fat and appropriate amino acid formula. The special needs of energy-supplying nutrients increase the proportion of fat emulsions in parenteral nutrition formula, reduce the proportion of amino acids and glucose, determine the needs of vitamins and minerals, are safe and effective in children, and can maintain the blood of patients after infusion. Ketones are in the ideal range and blood sugar is also in the normal range, do not induce seizures in patients (or induce hyperlactatemia in patients with abnormal glucose metabolism), and effectively meet the nutritional needs of patients taking the ketogenic diet during fasting; the fat of the formula These substances can prevent hyperlipidemia, liver damage, cholestasis, and minimize the adverse reactions of high-fat formulas; the formula has enhanced doses of vitamin B2, niacin, and pantothenic acid, which can accelerate fat beta oxidation and further reduce fat overload. Possibly; the osmotic pressure of the parenteral nutrition formula is less than 600mOsm/L, which is within the range that the peripheral vein can tolerate (900mOsm/L), the patient feels less pain during infusion, and it is not easy to cause vasculitis; the glucose is medical Glucose in glucose solution, a small amount of glucose solution can balance fat metabolism without affecting ketone production, and at the same time reduce the probability of hypoglycemia; emulsifier makes fatty substances into an absorbable form; the role of minerals is to maintain normal physiological functions of the human body ; The role of amino acids guarantees children's demand for essential amino acids and avoids negative nitrogen balance; Sodium acetate is the mode of existence of anhydrous acetic acid in the final solution, and anhydrous acetic acid is to stabilize the pH of the ketogenic nutrient solution at an acceptable level for the human body within the range to ensure the safety of infusion.

在上述技术方案的基础上,本发明还可以做如下改进:On the basis of above-mentioned technical scheme, the present invention can also do following improvement:

进一步,所述脂肪重量与所述葡萄糖和所述氨基酸重量之和的比例为2:1~4:1,所述氨基酸为18种或者19种。Further, the ratio of the weight of the fat to the sum of the weight of the glucose and the amino acid is 2:1 to 4:1, and the number of the amino acids is 18 or 19.

采用上述进一步方案的有益效果是氨基酸为19种氨基酸适用于3岁以下儿童,氨基酸为18种适用于3岁及以上人群,能够满足不同年龄段患者对氨基酸的不同需求。The beneficial effect of the above-mentioned further scheme is that 19 kinds of amino acids are suitable for children under 3 years old, and 18 kinds of amino acids are suitable for people over 3 years old, which can meet the different needs of patients of different ages for amino acids.

进一步,所述18种氨基酸为异亮氨酸、亮氨酸、赖氨酸、甲硫氨酸、苯丙氨酸、苏氨酸、色氨酸、缬氨酸、胱氨酸、组氨酸、酪氨酸、丙氨酸、精氨酸、脯氨酸、丝氨酸、门冬氨酸、谷氨酸和甘氨酸;各种氨基酸的质量比为异亮氨酸:亮氨酸:赖氨酸:甲硫氨酸:苯丙氨酸:苏氨酸:色氨酸:缬氨酸:胱氨酸:组氨酸:酪氨酸:丙氨酸:精氨酸:脯氨酸:丝氨酸:门冬氨酸:谷氨酸:甘氨酸=33:56:23:13:19:17:8:31:1:19:9:21:49:27:15:13:20:15。Further, the 18 amino acids are isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine, cystine, histidine , tyrosine, alanine, arginine, proline, serine, aspartic acid, glutamic acid and glycine; the mass ratio of various amino acids is isoleucine:leucine:lysine: Methionine: Phenylalanine: Threonine: Tryptophan: Valine: Cystine: Histidine: Tyrosine: Alanine: Arginine: Proline: Serine: Aspart Amino acid: glutamic acid: glycine = 33:56:23:13:19:17:8:31:1:19:9:21:49:27:15:13:20:15.

采用上述进一步方案的有益效果是平衡基酸模式,提高氨基酸利用率。The beneficial effect of adopting the above-mentioned further scheme is to balance the amino acid pattern and improve the utilization rate of amino acids.

进一步,所述19种氨基酸为异亮氨酸、亮氨酸、赖氨酸、甲硫氨酸、苯丙氨酸、苏氨酸、色氨酸、缬氨酸、半胱氨酸、组氨酸、酪氨酸、丙氨酸、精氨酸、脯氨酸、丝氨酸、门冬氨酸、谷氨酸、甘氨酸和牛磺酸;各种氨基酸的质量比为异亮氨酸:亮氨酸:赖氨酸:甲硫氨酸:苯丙氨酸:苏氨酸:色氨酸:缬氨酸:半胱氨酸:组氨酸:酪氨酸:丙氨酸:精氨酸:脯氨酸:丝氨酸:门冬氨酸:谷氨酸:甘氨酸:牛磺酸=33:56:23:13:19:17:8:31:1:19:9:21:49:27:15:13:20:15:1。Further, the 19 amino acids are isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine, cysteine, histidine acid, tyrosine, alanine, arginine, proline, serine, aspartic acid, glutamic acid, glycine and taurine; the mass ratio of various amino acids is isoleucine:leucine: Lysine: Methionine: Phenylalanine: Threonine: Tryptophan: Valine: Cysteine: Histidine: Tyrosine: Alanine: Arginine: Proline :serine:aspartic acid:glutamic acid:glycine:taurine=33:56:23:13:19:17:8:31:1:19:9:21:49:27:15:13: 20:15:1.

采用上述进一步方案的有益效果是平衡氨基酸模式,提高氨基酸利用率,同时满足3岁以下儿童的氨基酸需求。The beneficial effect of adopting the above-mentioned further scheme is to balance the amino acid pattern, improve the utilization rate of amino acids, and meet the amino acid requirements of children under 3 years old at the same time.

进一步,所述脂肪类物质为中链甘油三酯、橄榄油、大豆油和鱼油,所述脂肪类物质各组分的质量比为中链甘油三酯:橄榄油:大豆油:鱼油=7:4:7:2;所述乳化剂为蛋黄卵磷脂、甘油、油酸钠,所述乳化剂各组分的质量比为蛋黄卵磷脂:甘油:油酸钠=43:89:1。Further, the fatty substance is medium chain triglyceride, olive oil, soybean oil and fish oil, and the mass ratio of each component of the fatty substance is medium chain triglyceride: olive oil: soybean oil: fish oil=7: 4:7:2; the emulsifier is egg yolk lecithin, glycerol, and sodium oleate, and the mass ratio of each component of the emulsifier is egg yolk lecithin:glycerol:sodium oleate=43:89:1.

采用上述进一步方案的有益效果是中链脂肪可以快速入肝氧化生成酮体供能,橄榄油可以提供单不饱和脂肪酸,大豆油可以满足必需脂肪酸需求,鱼油可以调节免疫反应并控制炎症反应,多种油合理的比例混合,可以大大降低本高脂肪肠外营养配方造成高血脂、肝损害、胆汁淤积的风险;三种乳化剂的加入使得油类物质能够有效乳化成能够被人体吸收的形式。The beneficial effect of adopting the above-mentioned further scheme is that medium-chain fat can be rapidly oxidized into the liver to generate ketone bodies for energy supply, olive oil can provide monounsaturated fatty acids, soybean oil can meet the needs of essential fatty acids, fish oil can regulate immune response and control inflammatory response, and more Mixing these oils in a reasonable proportion can greatly reduce the risk of hyperlipidemia, liver damage and cholestasis caused by this high-fat parenteral nutrition formula; the addition of three emulsifiers enables the oil substances to be effectively emulsified into a form that can be absorbed by the human body.

进一步,所述维生素为脂溶性维生素和水溶性维生素的混合物,所述脂溶性维生素为维生素A、维生素D2、维生素E和维生素K1,所述水溶性维生素为维生素B1、维生素B2、烟酸、维生素B6、泛酸、维生素C、生物素、叶酸和维生素B12,各种维生素的质量比为维生素A:维生素D2:维生素E:维生素K1:维生素B1:维生素B2:烟酸:维生素B6:泛酸:维生素C:生物素:叶酸:维生素B12=700:10:7000:300:3800:9000:100000:5000:38000:125000:75:500:6.3。Further, the vitamins are a mixture of fat-soluble vitamins and water-soluble vitamins, the fat-soluble vitamins are vitamin A, vitamin D 2 , vitamin E and vitamin K 1 , and the water-soluble vitamins are vitamin B 1 , vitamin B 2 , Niacin, vitamin B 6 , pantothenic acid, vitamin C, biotin, folic acid and vitamin B 12 , the mass ratio of various vitamins is vitamin A: vitamin D 2 : vitamin E: vitamin K 1 : vitamin B 1 : vitamin B 2 : Niacin: vitamin B6: pantothenic acid: vitamin C: biotin: folic acid: vitamin B12 = 700: 10 :7000: 300 :3800:9000:100000:5000:38000:125000:75:500:6.3.

采用上述进一步方案的有益效果是其中特别强化了维生素B2、烟酸、泛酸的剂量,有利于加快脂肪β氧化,避免高脂配方相关的不良反应。The beneficial effect of adopting the above-mentioned further scheme is that the doses of vitamin B2, niacin, and pantothenic acid are specially strengthened, which is beneficial to accelerate the β-oxidation of fat and avoid the adverse reactions related to the high-fat formula.

进一步,所述矿物质为钠、钾、氯、锌、铜、锰、硒、氟和碘,所述矿物质各组分的质量比为钠:钾:氯:锌:铜:锰:硒:氟:碘=52000:88000:187000:250:20:1:2:57:1。Further, the minerals are sodium, potassium, chlorine, zinc, copper, manganese, selenium, fluorine and iodine, and the mass ratio of each component of the minerals is sodium: potassium: chlorine: zinc: copper: manganese: selenium: Fluorine:Iodine=52000:88000:187000:250:20:1:2:57:1.

采用上述进一步方案的有益效果是保证儿童对不同矿物质的不同日常需求,维持正常生理功能。The beneficial effect of adopting the above-mentioned further scheme is to ensure that children have different daily requirements for different minerals and maintain normal physiological functions.

一种生酮肠外营养液的制备方法,包括如下步骤:A preparation method of a ketogenic parenteral nutrition solution, comprising the following steps:

步骤1:称取对应量的氨基酸和对用量的无水醋酸与注射用水配制成氨基酸溶液,称取对应量的葡萄糖与注射用水配制成葡萄糖溶液,称取对应量的脂肪类物质,对应量的乳化剂和对应量的氢氧化钠与注射用水配制成脂肪乳剂;Step 1: Weigh the corresponding amount of amino acid and the corresponding amount of anhydrous acetic acid and water for injection to prepare an amino acid solution, weigh the corresponding amount of glucose and water for injection to prepare a glucose solution, weigh the corresponding amount of fatty substances, and weigh the corresponding amount of fatty substances. Emulsifier and corresponding amount of sodium hydroxide and water for injection are formulated into fat emulsion;

步骤2:称取对应量的矿物质,加入步骤1中的氨基酸溶液,得到第一混合液;Step 2: Weigh the corresponding amount of minerals, add the amino acid solution in Step 1 to obtain the first mixed solution;

步骤3:称取对应量的维生素,将所述维生素中脂溶性的维生素加入步Step 3: Weigh the corresponding amount of vitamins, and add the fat-soluble vitamins in the vitamins to step 3.

骤1中的脂肪乳剂,得到第二混合液;将所述维生素中水溶性的维生素The fat emulsion in step 1 obtains the second mixed solution; the water-soluble vitamins in the vitamins are

加入步骤1中的葡萄糖溶液,得到第三混合液;Add the glucose solution in step 1 to obtain the third mixed solution;

步骤4:将步骤2中的第一混合液与步骤3中的第二混合液和第三混合液混合,得到所述生酮肠外营养液。Step 4: Mix the first mixed solution in step 2 with the second mixed solution and the third mixed solution in step 3 to obtain the ketogenic parenteral nutrition solution.

采用上述进一步方案的有益效果是通过合理的步骤,使得各成分能够充分发挥作用。The beneficial effect of adopting the above-mentioned further scheme is that through reasonable steps, each component can fully function.

进一步,所述氨基酸溶液中氨基酸的质量浓度为6%或10%,所述葡萄糖溶液的质量浓度为10%,所述脂肪乳剂中油类物质的质量浓度为20%。Further, the mass concentration of amino acids in the amino acid solution is 6% or 10%, the mass concentration of the glucose solution is 10%, and the mass concentration of oil substances in the fat emulsion is 20%.

采用上述进一步方案的有益效果是选用合适的浓度结合用量得到所需浓度的生酮肠外营养液。The beneficial effect of adopting the above-mentioned further scheme is to select the appropriate concentration and dosage to obtain the ketogenic parenteral nutrition solution of the desired concentration.

进一步,还包括补充水分的步骤,在所述步骤4中将第一混合液、第二混合液和第三混合液混合后,补充水分至一定浓度。Further, it also includes a step of replenishing water. In the step 4, after mixing the first mixed solution, the second mixed solution and the third mixed solution, add water to a certain concentration.

采用上述进一步方案的有益效果是将第一混合液、第二混合液和第三混合液混合后补充水分得到所需浓度的生酮肠外营养液。The beneficial effect of adopting the above-mentioned further solution is that the first mixed solution, the second mixed solution and the third mixed solution are mixed and then supplemented with water to obtain a ketogenic parenteral nutrition solution with a desired concentration.

具体实施方式Detailed ways

以下对本发明的原理和特征进行描述,所举实例只用于解释本发明,并非用于限定本发明的范围。The principles and features of the present invention are described below, and the examples are only used to explain the present invention, but not to limit the scope of the present invention.

实施例1Example 1

本实施例为4:1型生酮(脂肪类物质重量:葡萄糖和氨基酸重量之和为4:1),适用于3岁以下儿童。肠外生酮营养液的参数为能量:80.3kcal/100ml,渗透压:421mOsm/L,氨基酸1.8g/100mL,脂肪类物质8.0g/100mL,葡萄糖0.2g/100mL,维生素28.93mg/100mL,矿物质327.33mg/ml,乳化剂1.49g/100mL,醋酸钠2.34mmol/100mL。This example is 4:1 ketogenic (the weight of fatty substances: the sum of the weight of glucose and amino acids is 4:1), which is suitable for children under 3 years old. The parameters of parenteral ketogenic nutrient solution are energy: 80.3kcal/100ml, osmotic pressure: 421mOsm/L, amino acid 1.8g/100mL, fatty substance 8.0g/100mL, glucose 0.2g/100mL, vitamin 28.93mg/100mL, mineral Substance 327.33mg/ml, emulsifier 1.49g/100mL, sodium acetate 2.34mmol/100mL.

生酮肠外营养液的制备方法:Preparation method of ketogenic parenteral nutrition solution:

步骤1:称取对应量的氨基酸和无水醋酸与注射用水配制成氨基酸溶液,称取对应量的葡萄糖与注射用水配制成葡萄糖溶液,称取对应量的脂肪类物质、乳化剂和氢氧化钠与注射用水配制成脂肪乳剂;Step 1: Weigh corresponding amounts of amino acids and anhydrous acetic acid and water for injection to prepare amino acid solution, take corresponding amounts of glucose and water for injection to prepare glucose solution, weigh corresponding amounts of fatty substances, emulsifier and sodium hydroxide It is formulated into a fat emulsion with water for injection;

步骤2:称取对应量的矿物质,加入步骤1中的氨基酸溶液,得到第一混合液;Step 2: Weigh the corresponding amount of minerals, add the amino acid solution in Step 1 to obtain the first mixed solution;

步骤3:称取对应量的维生素,将所述维生素中脂溶性的维生素加入步骤1中的脂肪乳剂,得到第二混合液;将所述维生素中水溶性的维生素加入步骤1中的葡萄糖溶液,得到第三混合液;Step 3: Weigh the corresponding amount of vitamins, add the fat-soluble vitamins in the vitamins to the fat emulsion in step 1 to obtain a second mixed solution; add the water-soluble vitamins in the vitamins to the glucose solution in step 1, to obtain the third mixed solution;

步骤4:将步骤2中的第一混合液与步骤3中的第二混合液和第三混合液混合,补充注射用水,得到生酮肠外营养液。Step 4: Mix the first mixed solution in step 2 with the second mixed solution and the third mixed solution in step 3, and supplement water for injection to obtain a ketogenic parenteral nutrition solution.

实施例2Example 2

本实施例为3:1型生酮(脂肪类物质重量:葡萄糖和氨基酸重量之和为3:1),适用于3岁以下儿童。肠外生酮营养液的参数为能量:73.6kcal/100ml,渗透压:428mOsm/L,氨基酸1.98g/100mL,脂肪类物质7.1g/100mL,葡萄糖0.35g/100mL,维生素28.93mg/100mL,矿物质327.33mg/ml,乳化剂1.32g/100mL,醋酸钠2.57mmol/100mL。This example is 3:1 ketogenic (the weight of fatty substances: the sum of the weight of glucose and amino acids is 3:1), which is suitable for children under 3 years old. The parameters of parenteral ketogenic nutrient solution are energy: 73.6kcal/100ml, osmotic pressure: 428mOsm/L, amino acid 1.98g/100mL, fatty substance 7.1g/100mL, glucose 0.35g/100mL, vitamin 28.93mg/100mL, mineral Substance 327.33mg/ml, emulsifier 1.32g/100mL, sodium acetate 2.57mmol/100mL.

生酮肠外营养液的制备方法:The preparation method of ketogenic parenteral nutrition solution:

步骤1:称取对应量的氨基酸和无水醋酸与注射用水配制成氨基酸溶液,称取对应量的葡萄糖与注射用水配制成葡萄糖溶液,称取对应量的脂肪类物质、乳化剂和氢氧化钠与注射用水配制成脂肪乳剂;Step 1: Weigh corresponding amounts of amino acids and anhydrous acetic acid and water for injection to prepare amino acid solution, take corresponding amounts of glucose and water for injection to prepare glucose solution, weigh corresponding amounts of fatty substances, emulsifier and sodium hydroxide It is formulated into a fat emulsion with water for injection;

步骤2:称取对应量的矿物质,加入步骤1中的氨基酸溶液,得到第一混合液;Step 2: Weigh the corresponding amount of minerals, add the amino acid solution in Step 1 to obtain the first mixed solution;

步骤3:称取对应量的维生素,将所述维生素中脂溶性的维生素加入步骤1中的脂肪乳剂,得到第二混合液;将所述维生素中水溶性的维生素加入步骤1中的葡萄糖溶液,得到第三混合液;Step 3: Weigh the corresponding amount of vitamins, add the fat-soluble vitamins in the vitamins to the fat emulsion in step 1 to obtain a second mixed solution; add the water-soluble vitamins in the vitamins to the glucose solution in step 1, to obtain the third mixed solution;

步骤4:将步骤2中的第一混合液与步骤3中的第二混合液和第三混合液混合,补充注射用水,得到生酮肠外营养液。Step 4: Mix the first mixed solution in step 2 with the second mixed solution and the third mixed solution in step 3, and supplement water for injection to obtain a ketogenic parenteral nutrition solution.

实施例3Example 3

本实施例为2:1型生酮(脂肪类物质重量:葡萄糖和氨基酸重量之和为2:1),3岁以上人群适用,肠外生酮营养液的参数为能量:79.6kcal/100ml,渗透压:554mOsm/L,氨基酸3.3g/100mL,脂肪类物质7.2g/100mL,葡萄糖0.3g/100mL,维生素28.93mg/100mL,矿物质327.33mg/ml,乳化剂1.34g/100mL,醋酸钠4.29mmol/100mL。This example is 2:1 type ketogenic (weight of fatty substances: the sum of the weight of glucose and amino acid is 2:1), suitable for people over 3 years old, and the parameter of parenteral ketogenic nutrient solution is energy: 79.6kcal/100ml, Osmotic pressure: 554mOsm/L, amino acids 3.3g/100mL, fatty substances 7.2g/100mL, glucose 0.3g/100mL, vitamins 28.93mg/100mL, minerals 327.33mg/ml, emulsifier 1.34g/100mL, sodium acetate 4.29 mmol/100mL.

生酮肠外营养液的制备方法:Preparation method of ketogenic parenteral nutrition solution:

步骤1:称取对应量的氨基酸和无水醋酸与注射用水配制成氨基酸溶液,称取对应量的葡萄糖与注射用水配制成葡萄糖溶液,称取对应量的脂肪类物质、乳化剂和氢氧化钠与注射用水配制成脂肪乳剂;Step 1: Weigh corresponding amounts of amino acids and anhydrous acetic acid and water for injection to prepare amino acid solution, take corresponding amounts of glucose and water for injection to prepare glucose solution, weigh corresponding amounts of fatty substances, emulsifier and sodium hydroxide It is formulated into a fat emulsion with water for injection;

步骤2:称取对应量的矿物质,加入步骤1中的氨基酸溶液,得到第一混合液;Step 2: Weigh the corresponding amount of minerals, add the amino acid solution in Step 1 to obtain the first mixed solution;

步骤3:称取对应量的维生素,将所述维生素中脂溶性的维生素加入步骤1中的脂肪乳剂,得到第二混合液;将所述维生素中水溶性的维生素加入步骤1中的葡萄糖溶液,得到第三混合液;Step 3: Weigh the corresponding amount of vitamins, add the fat-soluble vitamins in the vitamins to the fat emulsion in step 1 to obtain a second mixed solution; add the water-soluble vitamins in the vitamins to the glucose solution in step 1, to obtain the third mixed solution;

步骤4:将步骤2中的第一混合液与步骤3中的第二混合液和第三混合液混合,补充注射用水,得到生酮肠外营养液。Step 4: Mix the first mixed solution in step 2 with the second mixed solution and the third mixed solution in step 3, and supplement water for injection to obtain a ketogenic parenteral nutrition solution.

实施例4Example 4

本实施例为2.5:1型生酮(脂肪类物质重量:葡萄糖和氨基酸重量之和为2.5:1),3岁以上人群适用,肠外生酮营养液的参数为能量:68.9kcal/100ml,渗透压:477mOsm/L,氨基酸1.9g/100mL,脂肪类物质6.5g/100mL,葡萄糖0.7g/100mL,维生素28.93mg/100mL,矿物质327.33mg/ml,乳化剂1.34g/100mL,醋酸钠2.47mmol/100mL。This example is 2.5:1 type ketogenic (the weight of fatty substances: the sum of the weight of glucose and amino acid is 2.5:1), suitable for people over 3 years old, and the parameters of the parenteral ketogenic nutrient solution are energy: 68.9kcal/100ml, Osmotic pressure: 477mOsm/L, amino acids 1.9g/100mL, fatty substances 6.5g/100mL, glucose 0.7g/100mL, vitamins 28.93mg/100mL, minerals 327.33mg/ml, emulsifier 1.34g/100mL, sodium acetate 2.47 mmol/100mL.

生酮肠外营养液的制备方法:The preparation method of ketogenic parenteral nutrition solution:

步骤1:step 1:

步骤1:称取对应量的氨基酸和无水醋酸与注射用水配制成氨基酸溶液,称取对应量的葡萄糖与注射用水配制成葡萄糖溶液,称取对应量的脂肪类物质、乳化剂和氢氧化钠与注射用水配制成脂肪乳剂;Step 1: Weigh corresponding amounts of amino acids and anhydrous acetic acid and water for injection to prepare amino acid solution, take corresponding amounts of glucose and water for injection to prepare glucose solution, weigh corresponding amounts of fatty substances, emulsifier and sodium hydroxide It is formulated into a fat emulsion with water for injection;

步骤2:称取对应量的矿物质,加入步骤1中的氨基酸溶液,得到第一混合液;Step 2: Weigh the corresponding amount of minerals, add the amino acid solution in Step 1 to obtain the first mixed solution;

步骤3:称取对应量的维生素,将所述维生素中脂溶性的维生素加入步骤1中的脂肪乳剂,得到第二混合液;将所述维生素中水溶性的维生素加入步骤1中的葡萄糖溶液,得到第三混合液;Step 3: Weigh the corresponding amount of vitamins, add the fat-soluble vitamins in the vitamins to the fat emulsion in step 1 to obtain a second mixed solution; add the water-soluble vitamins in the vitamins to the glucose solution in step 1, to obtain the third mixed solution;

步骤4:将步骤2中的第一混合液与步骤3中的第二混合液和第三混合液混合,补充注射用水,得到生酮肠外营养液。Step 4: Mix the first mixed solution in step 2 with the second mixed solution and the third mixed solution in step 3, and supplement water for injection to obtain a ketogenic parenteral nutrition solution.

实施例5Example 5

本实施例为3.5:1型生酮(脂肪类物质重量:葡萄糖和氨基酸重量之和为3.5:1),3岁以上人群适用,肠外生酮营养液的参数为能量:68.9kcal/100ml,渗透压:436mOsm/L,氨基酸1.84g/100mL,脂肪类物质7.91g/100mL,葡萄糖0.42g/100mL,维生素28.93mg/100mL,矿物质327.33mg/ml,乳化剂1.48g/100mL,醋酸钠2.39mmol/100mL。This example is 3.5:1 type ketogenic (the weight of fatty substances: the sum of the weight of glucose and amino acids is 3.5:1), suitable for people over 3 years old, and the parameters of the parenteral ketogenic nutrient solution are energy: 68.9kcal/100ml, Osmotic pressure: 436mOsm/L, amino acids 1.84g/100mL, fatty substances 7.91g/100mL, glucose 0.42g/100mL, vitamins 28.93mg/100mL, minerals 327.33mg/ml, emulsifier 1.48g/100mL, sodium acetate 2.39 mmol/100mL.

生酮肠外营养液的制备方法:Preparation method of ketogenic parenteral nutrition solution:

步骤1:称取对应量的氨基酸和无水醋酸与注射用水配制成氨基酸溶液,称取对应量的葡萄糖与注射用水配制成葡萄糖溶液,称取对应量的脂肪类物质、乳化剂和氢氧化钠与注射用水配制成脂肪乳剂;Step 1: Weigh corresponding amounts of amino acids and anhydrous acetic acid and water for injection to prepare amino acid solution, take corresponding amounts of glucose and water for injection to prepare glucose solution, weigh corresponding amounts of fatty substances, emulsifier and sodium hydroxide It is formulated into a fat emulsion with water for injection;

步骤2:称取对应量的矿物质,加入步骤1中的氨基酸溶液,得到第一混合液;Step 2: Weigh the corresponding amount of minerals, add the amino acid solution in Step 1 to obtain the first mixed solution;

步骤3:称取对应量的维生素,将所述维生素中脂溶性的维生素加入步骤1中的脂肪乳剂,得到第二混合液;将所述维生素中水溶性的维生素加入步骤1中的葡萄糖溶液,得到第三混合液;Step 3: Weigh the corresponding amount of vitamins, add the fat-soluble vitamins in the vitamins to the fat emulsion in step 1 to obtain a second mixed solution; add the water-soluble vitamins in the vitamins to the glucose solution in step 1, to obtain the third mixed solution;

步骤4:将步骤2中的第一混合液与步骤3中的第二混合液和第三混合液混合,补充注射用水,得到生酮肠外营养液。Step 4: Mix the first mixed solution in step 2 with the second mixed solution and the third mixed solution in step 3, and supplement water for injection to obtain a ketogenic parenteral nutrition solution.

需要说明的是上述氨基酸溶液、葡萄糖溶液和脂肪乳剂均可通过商业购买,购买后直接根据所需用量直接用于配制;或者商业定制:向生产厂家定制特定浓度的溶液,厂家通过现有技术得到对应浓度的氨基酸溶液、葡萄糖溶液和脂肪乳剂。It should be noted that the above-mentioned amino acid solution, glucose solution and fat emulsion can be purchased commercially, and can be directly used for preparation according to the required amount after purchase; or commercial customization: a solution of a specific concentration is customized to the manufacturer, and the manufacturer obtains it through the existing technology. Corresponding concentrations of amino acid solution, glucose solution and fat emulsion.

现有技术可通过将氨基酸配制成氨基酸溶液的过程包括称取对应量的氨基酸、无水醋酸和注射用水通过搅拌、过滤、冷冻、干燥等步骤配制成氨基酸溶液;将葡萄糖配制成葡萄糖溶液的过程包括称取对应量的葡萄糖,加入注射用水,搅拌,配制成葡萄糖溶液;称取对应量的脂肪类物质、乳化剂制备油相和水相,然后搅拌混合,加入氢氧化钠、加注射用水、均质等步骤配制成脂肪乳剂。In the prior art, the process of preparing amino acids into amino acid solutions includes weighing corresponding amounts of amino acids, anhydrous acetic acid and water for injection to prepare amino acid solutions through steps such as stirring, filtration, freezing, and drying; the process of preparing glucose into glucose solutions. Including weighing the corresponding amount of glucose, adding water for injection, stirring to prepare a glucose solution; weighing the corresponding amount of fatty substances and emulsifiers to prepare oil phase and water phase, then stirring and mixing, adding sodium hydroxide, adding water for injection, Steps such as homogenization are formulated into a fat emulsion.

上述生酮肠外营养液的制备方法中,步骤3中将所述维生素中脂溶性的维生素加入步骤1中的脂肪乳剂,得到第二混合液;将所述维生素中水溶性的维生素加入步骤1中的葡萄糖溶液,得到第三混合液。如果权利要求1中维生素只有脂溶性维生素,则步骤3只包括将所述维生素中脂溶性的维生素加入步骤1中的脂肪乳剂,得到第二混合液,之后将第一混合液、第二混合液和葡萄糖溶液混合,(如需补水则补水),得到生酮肠外营养液。如果权利要求1中维生素只有水溶性维生素,则步骤3只包括将所述维生素中水溶性的维生素加入步骤1中的葡萄糖溶液,得到第三混合液,之后将第一混合液、脂肪乳剂和第三混合液混合,(如需补水则补水),得到生酮肠外营养液。In the preparation method of the above-mentioned ketogenic parenteral nutrition solution, in step 3, the fat-soluble vitamins in the vitamins are added to the fat emulsion in step 1 to obtain a second mixed solution; the water-soluble vitamins in the vitamins are added in step 1 in the glucose solution to obtain the third mixed solution. If the vitamins in claim 1 are only fat-soluble vitamins, then step 3 only includes adding the fat-soluble vitamins in the vitamins to the fat emulsion in step 1 to obtain a second mixed solution, and then adding the first mixed solution and the second mixed solution. It is mixed with glucose solution (replenish water if necessary) to obtain ketogenic parenteral nutrition solution. If the vitamins in claim 1 are only water-soluble vitamins, then step 3 only includes adding the water-soluble vitamins in the vitamins to the glucose solution in step 1 to obtain a third mixed solution, and then adding the first mixed solution, the fat emulsion and the first mixed solution. The three mixed solutions are mixed, (replenish water if necessary) to obtain a ketogenic parenteral nutrition solution.

对应量的无水醋酸和对应量的氢氧化钠指的是和所需营养液中醋酸钠具有相同摩尔数的醋酸和氢氧化钠;步骤4中第一混合液和第二混合液的混合,使得醋酸和氢氧化钠反应生成营养液中的醋酸钠。The anhydrous acetic acid of the corresponding amount and the sodium hydroxide of the corresponding amount refer to the acetic acid and the sodium hydroxide having the same mole number as the sodium acetate in the required nutrient solution; the mixing of the first mixed solution and the second mixed solution in step 4, The acetic acid and sodium hydroxide are reacted to form sodium acetate in the nutrient solution.

所述氨基酸溶液的氨基酸优选配制质量浓度为6%或10%,所述葡萄糖溶液的优选配制质量浓度为10%,所述脂肪乳剂中油类物质的优选配制质量浓度为20%。当氨基酸为19种时,氨基酸溶液的优选配制质量浓度为6%;当氨基酸为18种时,氨基酸溶液的优选配制质量浓度为10%。The amino acid of the amino acid solution is preferably formulated at a mass concentration of 6% or 10%, the glucose solution is preferably formulated at a mass concentration of 10%, and the oil in the fat emulsion is preferably formulated at a mass concentration of 20%. When there are 19 kinds of amino acids, the preferred preparation mass concentration of the amino acid solution is 6%; when there are 18 kinds of amino acids, the preferred preparation mass concentration of the amino acid solution is 10%.

本发明中根据各物质所需重量来称量,称量选用不同精度的称量仪器,所产生的误差不影响本发明中各物质在所配制营养液中作用的发挥。称量需要精确到十分位的物质选用精确到0.1g的电子天平,称量需要精确到百分位的物质选用精确到0.01g的电子天平,称量需要精确到千分位的物质选用精确到0.001g的电子天平。In the present invention, each substance is weighed according to the required weight, and weighing instruments with different precisions are used for weighing. For substances that need to be weighed to the tenth place, choose an electronic balance that is accurate to 0.1g. For substances that need to be weighed to the percentile, choose an electronic balance that is accurate to 0.01g. 0.001g electronic balance.

本发明制定了使用的时间、速度和监测指标:要求本发明营养液连续使用时间不超过2周;根据脂肪的量来确定输注时间,一定脂肪量的输注时间(小时)不短于所需输注脂肪类物质的重量/0.15/人体体重(其中脂肪类物质的质量以g计,人体重量以kg计)。每周需要复查肝肾功、电解质、血脂、血糖、血酮水平等,决定是否继续使用。The present invention formulates the time, speed and monitoring index of use: the continuous use time of the nutrient solution of the present invention is required not to exceed 2 weeks; the infusion time is determined according to the amount of fat, and the infusion time (hour) of a certain amount of fat is not shorter than the specified amount of fat. The weight of fatty substances to be infused/0.15/body weight (wherein the mass of fatty substances is in g, and the body weight is in kg). It is necessary to review liver and kidney function, electrolytes, blood lipids, blood sugar, blood ketone levels, etc. every week to decide whether to continue use.

本发明制定了使用的适应症和禁忌症。适应症:难治性癫痫、葡萄糖载体缺乏症、丙酮酸脱氢酶缺乏症等。禁忌症:所有脂肪利用障碍相关疾病、氨基酸代谢疾病急性期、严重肝肾功能损害等、慢性代谢性酸中毒、高脂血症、高血压或经临床医师评估后不能使用的疾病等。The present invention establishes the indications and contraindications for use. Indications: refractory epilepsy, glucose carrier deficiency, pyruvate dehydrogenase deficiency, etc. Contraindications: all diseases related to fat utilization disorders, acute phase of amino acid metabolism diseases, severe liver and kidney function damage, etc., chronic metabolic acidosis, hyperlipidemia, hypertension or diseases that cannot be used after evaluation by clinicians, etc.

所述脂肪类物质的重量与所述葡萄糖和所述氨基酸重量之和的比例为2:1~4:1时候生酮效果较好。When the ratio of the weight of the fatty substance to the sum of the weight of the glucose and the amino acid is 2:1 to 4:1, the ketogenic effect is better.

在临床上,4:1型、3:1型和2:1型生酮应用最为广泛,可根据病人情况从中进行选择,也可根据病人情况选用其他生酮比例。In clinical practice, 4:1 type, 3:1 type and 2:1 type of ketosis are the most widely used, which can be selected according to the patient's situation, or other ketogenic ratios can be selected according to the patient's situation.

效果说明Effect description

患者应用实例1Patient Application Example 1

患儿张某某,男,11月,婴儿痉挛症(8月开始生酮奶治疗发作),因“腹痛、腹胀、呕吐1天”收治入院;入院后腹部平片显示肠管积气明显且有液平;医生考虑主要诊断为1.完全性肠梗阻2.婴儿痉挛症;经治疗后病情平稳,需要短期肠外营养支持。此时,营养科医生介入制定营养方案:患儿体重8kg,目前肠外营养液空间为330ml。患儿平素使用4:1生酮奶进行治疗,故选用上述4:1型生酮肠外营养配方(3岁以下型)共330ml开始肠外营养输注,保证营养摄入,输注速度15ml/h,供需输注22小时。输注持续共5天,每天监测血酮血糖,血酮保持2.5mmol/L-4.5mmol/L,血糖3.5-4.8mol/L,期间无痉挛发作频率增加。经治疗5天后,肠梗阻逐渐缓解,开始增加生酮奶,减少生酮肠外营养液,2周后顺利出院,继续生酮奶喂养,临床营养门诊随访。The child Zhang Moumou, male, in November, suffered from infantile spasms (the onset of ketogenic milk treatment started in August), and was admitted to the hospital because of "abdominal pain, abdominal distension, and vomiting for 1 day". Fluid level; the doctor considered the main diagnosis as 1. Complete intestinal obstruction 2. Infantile spasms; after treatment, the condition was stable and short-term parenteral nutrition support was needed. At this time, the nutritionist intervened to formulate a nutritional plan: the child weighed 8kg, and the current space for parenteral nutrition was 330ml. Children usually use 4:1 ketogenic milk for treatment, so the above 4:1 ketogenic parenteral nutrition formula (under 3 years old) is used to start parenteral nutrition infusion with a total of 330ml to ensure nutritional intake, and the infusion rate is 15ml /h, supply and demand infusion for 22 hours. The infusion continued for a total of 5 days, and the blood ketones and blood glucose were monitored every day. After 5 days of treatment, the intestinal obstruction was gradually relieved, and the ketogenic milk was increased and the ketogenic parenteral nutrition solution was reduced. After 2 weeks, the patient was discharged from the hospital and continued to be fed with ketogenic milk. The clinical nutrition clinic was followed up.

患者应用实例2Patient application example 2

患儿王某某,女,4岁2,难治性癫痫(3岁开始生酮饮食治疗),因“上腹部胀痛10小时,伴有恶心及呕吐”收治入院;入院检查血淀粉酶1066U/L,脂肪酶4213U/L.血常规示:WBC15.77×109/L,N0.733.上腹部CT结果示急性胰腺炎。主要诊断为1.急性胰腺炎2.难治性癫痫;经治疗生命体征平稳后,需要短期肠外营养支持,请营养科会诊:患儿体重15kg,目前肠外营养液空间为520ml。患儿平常已使用2:1自制配餐进行三餐,自测血酮2.7~4.5mmol/L,血糖3.6~5.2mmol/L,病情控制稳定。重症胰腺炎虽然也可以采用鼻空肠管泵入高糖低脂短肽肠内配方进行空肠营养喂养,但患儿为长期生酮饮食治疗的难治性癫痫患者,冒然使用此方法可能导致癫痫发作。故短期仍然继续禁食,并选用上述2:1型生酮肠外营养配方(3岁以上型)开始肠外营养输注(液体520ml),输注速度38ml/h,供需输注13.6小时。持续输注时间共13天,每天监测血酮血糖,血酮保持2.2mmol/L~3.8mol/L,血糖3.3~4.3mol/L,期间癫痫发作频率无增加。第一周结束转氨酶、胆红素、血甘油三酯水平较入院时无明显升高。出院前,营养医师再次会诊:考虑患儿现癫痫发作频率低,病情控制稳定,但长期生酮饮食为可能为胰腺炎的诱发因素之一,建议逐渐下调生酮饮食比例,逐渐恢复普通饮食。The child Wang Moumou, female, 4 years old, 2, with refractory epilepsy (started ketogenic diet treatment at the age of 3), was admitted to the hospital because of "upper abdominal pain for 10 hours, accompanied by nausea and vomiting"; blood amylase was checked at 1066U. /L, lipase 4213U/L. Blood routine showed: WBC15.77×109/L, N0.733. Upper abdominal CT results showed acute pancreatitis. The main diagnosis is 1. acute pancreatitis 2. refractory epilepsy; after the vital signs are stable after treatment, short-term parenteral nutrition support is needed, please consult the nutrition department: the child weighs 15kg, and the current parenteral nutrition solution space is 520ml. The child has usually used a 2:1 homemade meal for three meals, self-measured blood ketones 2.7-4.5 mmol/L, blood sugar 3.6-5.2 mmol/L, and the condition is under stable control. Although severe pancreatitis can also be fed with high-sugar and low-fat short peptide enteral formula by nasojejunal tube, the child is a patient with refractory epilepsy treated with long-term ketogenic diet, and this method may lead to epilepsy. attack. Therefore, fasting was continued in the short term, and the above-mentioned 2:1 ketogenic parenteral nutrition formula (over 3 years old) was used to start parenteral nutrition infusion (liquid 520ml), the infusion rate was 38ml/h, and the supply and demand infusion was 13.6 hours. The continuous infusion time was 13 days, and the blood ketone and blood sugar were monitored every day. At the end of the first week, the levels of transaminase, bilirubin and blood triglyceride were not significantly higher than those at the time of admission. Before discharge, the nutritionist should consult again: Considering that the child has low seizure frequency and stable disease control, but long-term ketogenic diet may be one of the predisposing factors for pancreatitis, it is recommended to gradually reduce the proportion of ketogenic diet and gradually restore normal diet.

以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included in the protection of the present invention. within the range.

Claims (10)

1.一种生酮肠外营养液,其特征在于,包括溶解在注射用水中的以下物质:氨基酸、脂肪类物质、葡萄糖、维生素、矿物质、乳化剂和醋酸钠;1. a ketogenic parenteral nutrition solution, is characterized in that, comprises the following material dissolved in water for injection: amino acid, fatty substance, glucose, vitamin, mineral, emulsifier and sodium acetate; 各组分的质量分数为:氨基酸1.80~3.3g/100mL,脂肪类物质6.5~8.0g/100mL,葡萄糖0.2~0.7g/100mL,维生素28.93mg/100mL,矿物质327.33mg/100mL,乳化剂1.32~1.49g/100mL,醋酸钠2.34~4.29mmol/100mL。The mass fraction of each component is: amino acid 1.80~3.3g/100mL, fatty substance 6.5~8.0g/100mL, glucose 0.2~0.7g/100mL, vitamin 28.93mg/100mL, mineral 327.33mg/100mL, emulsifier 1.32 ~1.49g/100mL, sodium acetate 2.34~4.29mmol/100mL. 2.根据权利要求1所述一种生酮肠外营养液,其特征在于,所述脂肪类物质的重量与所述葡萄糖和所述氨基酸重量之和的比例为2:1~4:1,所述氨基酸为18种或者19种。2 . The ketogenic parenteral nutrition solution according to claim 1 , wherein the ratio of the weight of the fatty substance to the sum of the weight of the glucose and the amino acid is 2:1 to 4:1, 2 . The amino acids are 18 or 19. 3.根据权利要求2所述一种生酮肠外营养液,其特征在于,所述18种氨基酸为异亮氨酸、亮氨酸、赖氨酸、甲硫氨酸、苯丙氨酸、苏氨酸、色氨酸、缬氨酸、胱氨酸、组氨酸、酪氨酸、丙氨酸、精氨酸、脯氨酸、丝氨酸、门冬氨酸、谷氨酸和甘氨酸;各种氨基酸的质量比为异亮氨酸:亮氨酸:赖氨酸:甲硫氨酸:苯丙氨酸:苏氨酸:色氨酸:缬氨酸:胱氨酸:组氨酸:酪氨酸:丙氨酸:精氨酸:脯氨酸:丝氨酸:门冬氨酸:谷氨酸:甘氨酸=33:56:23:13:19:17:8:31:1:19:9:21:49:27:15:13:20:15。3. a kind of ketogenic parenteral nutrition solution according to claim 2, is characterized in that, described 18 kinds of amino acids are isoleucine, leucine, lysine, methionine, phenylalanine, Threonine, tryptophan, valine, cystine, histidine, tyrosine, alanine, arginine, proline, serine, aspartic acid, glutamic acid, and glycine; each The mass ratio of the amino acids is isoleucine:leucine:lysine:methionine:phenylalanine:threonine:tryptophan:valine:cystine:histidine:tyrosine Amino acid: Alanine: Arginine: Proline: Serine: Aspartic acid: Glutamic acid: Glycine = 33:56:23:13:19:17:8:31:1:19:9: 21:49:27:15:13:20:15. 4.根据权利要求2所述一种生酮肠外营养液,其特征在于,所述19种氨基酸为异亮氨酸、亮氨酸、赖氨酸、甲硫氨酸、苯丙氨酸、苏氨酸、色氨酸、缬氨酸、半胱氨酸、组氨酸、酪氨酸、丙氨酸、精氨酸、脯氨酸、丝氨酸、门冬氨酸、谷氨酸、甘氨酸和牛磺酸;各种氨基酸的质量比为异亮氨酸:亮氨酸:赖氨酸:甲硫氨酸:苯丙氨酸:苏氨酸:色氨酸:缬氨酸:半胱氨酸:组氨酸:酪氨酸:丙氨酸:精氨酸:脯氨酸:丝氨酸:门冬氨酸:谷氨酸:甘氨酸:牛磺酸=33:56:23:13:19:17:8:31:1:19:9:21:49:27:15:13:20:15:1。4. a kind of ketogenic parenteral nutrition solution according to claim 2, is characterized in that, described 19 kinds of amino acids are isoleucine, leucine, lysine, methionine, phenylalanine, Threonine, tryptophan, valine, cysteine, histidine, tyrosine, alanine, arginine, proline, serine, aspartic acid, glutamic acid, glycine and bovine Sulfonic acid; the mass ratio of various amino acids is isoleucine:leucine:lysine:methionine:phenylalanine:threonine:tryptophan:valine:cysteine: Histidine:tyrosine:alanine:arginine:proline:serine:aspartic acid:glutamic acid:glycine:taurine=33:56:23:13:19:17:8 :31:1:19:9:21:49:27:15:13:20:15:1. 5.根据权利要求1所述一种生酮肠外营养液,其特征在于,所述脂肪类物质为中链甘油三酯、橄榄油、大豆油和鱼油,所述脂肪类物质各组分的质量比为中链甘油三酯:橄榄油:大豆油:鱼油=7:4:7:2;所述乳化剂为蛋黄卵磷脂、甘油、油酸钠,所述乳化剂各组分的质量比为蛋黄卵磷脂:甘油:油酸钠=43:89:1。5. a kind of ketogenic parenteral nutrition solution according to claim 1, is characterized in that, described fatty substance is medium-chain triglyceride, olive oil, soybean oil and fish oil, and each component of described fatty substance is The mass ratio is medium chain triglyceride: olive oil: soybean oil: fish oil = 7:4:7:2; the emulsifier is egg yolk lecithin, glycerol, and sodium oleate, and the mass ratio of each component of the emulsifier is For egg lecithin: glycerol: sodium oleate = 43:89:1. 6.根据权利要求1所述一种生酮肠外营养液,其特征在于,所述维生素为脂溶性维生素和水溶性维生素的混合物,所述脂溶性维生素为维生素A、维生素D2、维生素E和维生素K1,所述水溶性维生素为维生素B1、维生素B2、烟酸、维生素B6、泛酸、维生素C、生物素、叶酸和维生素B12,各种维生素的质量比为维生素A:维生素D2:维生素E:维生素K1:维生素B1:维生素B2:烟酸:维生素B6:泛酸:维生素C:生物素:叶酸:维生素B12=700:10:7000:300:3800:9000:100000:5000:38000:125000:75:500:6.3。6. A ketogenic parenteral nutrition solution according to claim 1, wherein the vitamin is a mixture of a fat-soluble vitamin and a water-soluble vitamin, and the fat-soluble vitamin is vitamin A, vitamin D 2 , vitamin E and vitamin K 1 , the water-soluble vitamins are vitamin B 1 , vitamin B 2 , niacin, vitamin B 6 , pantothenic acid, vitamin C, biotin, folic acid and vitamin B 12 , and the mass ratio of various vitamins is vitamin A: Vitamin D 2 : Vitamin E: Vitamin K 1 : Vitamin B 1 : Vitamin B 2 : Niacin: Vitamin B 6 : Pantothenic acid: Vitamin C: Biotin: Folic acid: Vitamin B 12 =700:10:7000:300:3800: 9000:100000:5000:38000:125000:75:500:6.3. 7.根据权利要求1所述一种生酮肠外营养液,其特征在于,所述矿物质为钠、钾、氯、锌、铜、锰、硒、氟和碘,所述矿物质各组分的质量比为钠:钾:氯:锌:铜:锰:硒:氟:碘=52000:88000:187000:250:20:1:2:57:1。7. a kind of ketogenic parenteral nutrition solution according to claim 1, is characterized in that, described mineral is sodium, potassium, chlorine, zinc, copper, manganese, selenium, fluorine and iodine, and each group of described mineral The mass ratio of the points is sodium:potassium:chlorine:zinc:copper:manganese:selenium:fluorine:iodine=52000:88000:187000:250:20:1:2:57:1. 8.一种权利要求1-7任一项所述生酮肠外营养液的制备方法,其特征在于,包括如下步骤:8. a preparation method of the ketogenic parenteral nutrition solution described in any one of claims 1-7, is characterized in that, comprises the steps: 步骤1:称取对应量的氨基酸和对应量的无水醋酸与注射用水配制成氨基酸溶液,称取对应量的葡萄糖与注射用水配制成葡萄糖溶液,称取对应量的脂肪类物质、对应量的乳化剂和对应量的氢氧化钠与注射用水配制成脂肪乳剂;Step 1: take by weighing the corresponding amount of amino acid and corresponding amount of anhydrous acetic acid and water for injection to prepare amino acid solution, take by weighing corresponding amount of glucose and water for injection to prepare glucose solution, take by weighing corresponding amount of fatty substances, corresponding amount of Emulsifier and corresponding amount of sodium hydroxide and water for injection are formulated into fat emulsion; 步骤2:称取对应量的矿物质,加入步骤1中的氨基酸溶液,得到第一混合液;Step 2: Weigh the corresponding amount of minerals, add the amino acid solution in Step 1 to obtain the first mixed solution; 步骤3:称取对应量的维生素,将所述维生素中脂溶性的维生素加入步骤1中的脂肪乳剂,得到第二混合液;将所述维生素中水溶性的维生素加入步骤1中的葡萄糖溶液,得到第三混合液;Step 3: Weigh the corresponding amount of vitamins, add the fat-soluble vitamins in the vitamins to the fat emulsion in step 1 to obtain a second mixed solution; add the water-soluble vitamins in the vitamins to the glucose solution in step 1, to obtain the third mixed solution; 步骤4:将步骤2中的第一混合液与步骤3中的第二混合液和第三混合液混合,得到所述生酮肠外营养液。Step 4: Mix the first mixed solution in step 2 with the second mixed solution and the third mixed solution in step 3 to obtain the ketogenic parenteral nutrition solution. 9.根据权利要求8所述生酮肠外营养液的制备方法,其特征在于,所述氨基酸溶液中氨基酸的质量浓度为6%或10%,所述葡萄糖溶液的浓质量度为10%,所述脂肪乳剂中油类物质的质量浓度为20%。9. The preparation method of the ketogenic parenteral nutrition solution according to claim 8, wherein the amino acid mass concentration in the amino acid solution is 6% or 10%, and the glucose solution concentration mass concentration is 10%, The mass concentration of oil substances in the fat emulsion is 20%. 10.根据权利要求9所述生酮肠外营养液的制备方法,其特征在于,还包括补充水分的步骤,在所述步骤4中将第一混合液、第二混合液和第三混合液混合后,补充注射用水至一定浓度。10. the preparation method of ketogenic parenteral nutrition solution according to claim 9, is characterized in that, also comprises the step of replenishing moisture, in described step 4, the first mixed solution, the second mixed solution and the third mixed solution are After mixing, add water for injection to a certain concentration.
CN201910213658.3A 2019-03-20 2019-03-20 A kind of ketogenic parenteral nutrition solution and preparation method thereof Pending CN109939135A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910213658.3A CN109939135A (en) 2019-03-20 2019-03-20 A kind of ketogenic parenteral nutrition solution and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910213658.3A CN109939135A (en) 2019-03-20 2019-03-20 A kind of ketogenic parenteral nutrition solution and preparation method thereof

Publications (1)

Publication Number Publication Date
CN109939135A true CN109939135A (en) 2019-06-28

Family

ID=67010317

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910213658.3A Pending CN109939135A (en) 2019-03-20 2019-03-20 A kind of ketogenic parenteral nutrition solution and preparation method thereof

Country Status (1)

Country Link
CN (1) CN109939135A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111657497A (en) * 2020-06-28 2020-09-15 深圳市捷利康生物科技有限公司 Ketogenic diet for resisting food protein allergy and preparation method thereof
CN112656933A (en) * 2021-01-08 2021-04-16 天津市第三中心医院 Parenteral nutrient solution suitable for pneumonia patients

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1640396A (en) * 2004-01-02 2005-07-20 广东奇方药业有限公司 Novel medicinal compositions
CN106265857A (en) * 2015-05-19 2017-01-04 四川科伦药业股份有限公司 The preparation method of the fat milk of packed with three-cavity bag, aminoacid and glucose injection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1640396A (en) * 2004-01-02 2005-07-20 广东奇方药业有限公司 Novel medicinal compositions
CN106265857A (en) * 2015-05-19 2017-01-04 四川科伦药业股份有限公司 The preparation method of the fat milk of packed with three-cavity bag, aminoacid and glucose injection

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DE JUNG: "Safety and role of ketogenic parenteral nutrition for intractable childhood epilepsy", 《BRAIN & DEVELOPMENT》 *
史斌等: "《临床容量治疗学》", 31 December 2008, 天津科学技术出版社 *
广东省药学会: "肠外营养临床药学共识( 第二版)", 《今日药学》 *
营养学组: "《中国生理科学会学术会议论文摘要汇编 营养》", 31 August 1964 *
蔡华等: "《现代产科护理精要》", 30 September 2018, 天津科学技术出版社 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111657497A (en) * 2020-06-28 2020-09-15 深圳市捷利康生物科技有限公司 Ketogenic diet for resisting food protein allergy and preparation method thereof
CN112656933A (en) * 2021-01-08 2021-04-16 天津市第三中心医院 Parenteral nutrient solution suitable for pneumonia patients
CN112656933B (en) * 2021-01-08 2023-08-08 天津市第三中心医院 A parenteral nutrition solution suitable for patients with pneumonia

Similar Documents

Publication Publication Date Title
US4009265A (en) Methods and formulations for the treatment of obesity
RU2420209C2 (en) Long-term alimentation for cancer patient
KR101075816B1 (en) Total enteral nutritious composition
Pereira Nutritional care of the extremely premature infant
JPH08231411A (en) Method for feeding nutrition to aged patient
EP0630181A4 (en) Nutritional product for trauma and surgery patients.
US20120277170A1 (en) Nutritive compositions and methods of using same
Ahmed et al. Protein-energy malnutrition in children
CN109090580A (en) A kind of specific full nutritional formulas and preparation method thereof for tumor patient
Jain et al. Parenteral nutrition
CN105558046A (en) Formula food with special medicinal purpose and suitable for liver disease and preparation method thereof
CN109939135A (en) A kind of ketogenic parenteral nutrition solution and preparation method thereof
Littlewood et al. Rationale of modern dietary recommendations in cystic fibrosis
JP3137273B2 (en) Compositions effective for diabetes
Rohr et al. Reinstitution of pegvaliase therapy during lactation
CN105638900A (en) Special medical food for patients in emergency states and preparation method thereof
Rose et al. Nutrient needs of the preterm infant
Druml The renal failure patient
CN113519850A (en) Tumor total nutrient emulsion, preparation method and application thereof
Mehler et al. Treatment of anorexia nervosa with total parenteral nutrition
Tok et al. Vitamin D and Effective Mechanisms in the Control of Body Weight
Price Parenteral nutrition
Yuen et al. Treatment of Iatrogenic Essential Fatty Acid Deficiency with a Lipid-Rich Matrix in a Child with Intestinal Failure-Associated Liver Disease: Case Report
Acosta Evaluation of nutrition status
Starker et al. Parenteral nutrition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190628

RJ01 Rejection of invention patent application after publication